Breg Braak

The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome

Tamira K. Klooker, Breg Braak, Karin E. Koopman et al. · Gut · 2010 · 406 citations · Full text

Life Sciences, Immunology, Pharmacology +15

Lower striatal dopamine D2/3 receptor availability in obese compared with non-obese subjects

Barbara A. de Weijer, Elsmarieke van de Giessen, Thérèse A. van Amelsvoort et al. · EJNMMI Research · 2011 · 177 citations · Full text

Life Sciences, Neurobiology, Neuroscience +15

Mucosal Immune Cell Numbers and Visceral Sensitivity in Patients With Irritable Bowel Syndrome: Is There Any Relationship?

Breg Braak, Tamira K. Klooker, Mira M. Wouters et al. · The American Journal of Gastroenterology · 2012 · 93 citations

Life Sciences, Immunology, Pathology +17

Exposure to Severe Wartime Conditions in Early Life Is Associated With an Increased Risk of Irritable Bowel Syndrome: A Population-Based Cohort Study

Tamira K. Klooker, Breg Braak, Rebecca C. Painter et al. · The American Journal of Gastroenterology · 2009 · 81 citations

Public Health, Human Development, Epidemiologic Methods +14

Randomised clinical trial: the effects of amitriptyline on drinking capacity and symptoms in patients with functional dyspepsia, a double-blind placebo-controlled study

Breg Braak, Tamira K. Klooker, Mira M. Wouters et al. · Alimentary Pharmacology & Therapeutics · 2011 · 72 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15